We invest across Europe in early-stage biopharma companies developing new therapeutics

Biovance Capital Partners is a venture capital firm based in Lisbon that manages Biovance Capital Fund I. This is a €51 million biotech-focused fund backed by the European Investment Fund and other public and private investors.

Portfolio


Biovance Capital works closely with entrepreneurs to build leading companies with transformative treatments for patients in need. We invest in seed and Series A rounds and typically bring additional investors to add value and mitigate risk.


Our Network


We have developed a wide network across Europe that includes research institutes, incubators and accelerators. Through this network, we have access to a rich pipeline of potential investments.

Latest News